Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart drug enters Mid-Stage safety testing

NCT ID NCT06717074

Summary

This study is testing the safety and effects of an experimental drug called RBD4059 in adults with stable coronary artery disease, a condition where the heart's arteries are narrowed. Researchers will give the drug or a placebo (inactive substance) to 30 participants to see what side effects occur and how the drug behaves in the body. The goal is to see if the drug is safe enough to study further for controlling heart disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STABLE CORONARY ARTERY DISEASE CAD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ribocure Clinic

    Mölndal, 43153, Sweden

Conditions

Explore the condition pages connected to this study.